Table 3.
Key pathways associated with the long-term survival in GBM patients
| Row | Pathway | Gene expression |
CNV |
||
|---|---|---|---|---|---|
| PC 1 | PC 2 | PC 1 | PC 2 | ||
| 3 | Cytokine-cytokine receptor interaction | 0.0003 | 0.0008 | ||
| 4 | Chemokine signaling pathway | 0.0001 | 0.0001 | ||
| 5 | NOD-like receptor signaling pathway | 0.0003 | 0.0001 | ||
| 6 | ECM-receptor interaction | 0.0006 | |||
| 53 | Regulation of autophagy | 0.0006 | |||
| 54 | Glycosylphosphatidylinositol (GPI) anchor biosynthesis | 0.0005 | |||
| 81 | Neuroactive ligand-receptor interaction | 0.0005 | |||
| 82 | Long term depression | 0.0008 | |||
| 115 | Alpha linolenic acid metabolism | 0.0001 | 0.0002 | ||
| 116 | Linoleic acid metabolism | 0.0008 | 0.0007 | ||
Note: The column Row indicates the row numbers of pathways on pathway images.
PC, principal component; CNV, copy number variation.